![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)
Advertisers are leaning on convergent solutions to reach fragmented audiences Amy Leifer, Chief Advertising Sales Officer, DIRECTV Advertising For advertisers, it’s the most wonderful time of the year. Upfronts and...
Automatisering nam afgelopen jaren nauwelijks toe ondanks krappe arbeidsmarkt
Automatisering nam afgelopen jaren nauwelijks toe ondanks krappe arbeidsmarkt De automatisering van taken van werknemers nam de afgelopen jaren nauwelijks toe, ondanks de krapte op de arbeidsmarkt. Dat is de conclusie...
Commerce media grows more dominant by the year, forcing media agencies to keep pace with change
Commerce media grows more dominant by the year As the media and marketing industries grapple with economic worries that just won’t let up, instinctually marketers and agencies have turned to performance-driven options...
What downturn? In real terms, ad spending is doing just fine
What downturn? Ad spending is doing just fine The latest forecasts and financial updates are in and one thing is clear for ad spending this year: It isn’t speeding up but it isn’t slowing down much either. This is what...
Prescriptions for Chronic Conditions Underused in U.S. Jails, Prisons
Prescriptions for Chronic Conditions Underused in U.S. Jails Prescription medications for chronic conditions are substantially underused in U.S. jails and state prisons, according to a study published online April 14...
Most Children With ADHD Are Not Receiving Medications
Most Children With ADHD Are Not Receiving Medications Most children with parent-reported attention-deficit/hyperactivity disorder (ADHD) are not receiving medications and have never received outpatient mental health...
FDA Approves First Pill for Fecal Transplant Therapy
FDA Approves First Pill for Fecal Transplant Therapy The U.S. Food and Drug Administration on Wednesday approved the first pill form of fecal microbiota — similar to what’s known as fecal transplant therapy...
Doorbraak in behandeling van baby’s met agressieve leukemie
Doorbraak in behandeling van baby’s met agressieve leukemie Een nieuwe immuuntherapie voor baby’s met een agressieve vorm van leukemie vergroot de overlevingskansen aanzienlijk, blijkt uit nieuw onderzoek...
The FTC put pharma giants on notice for deceptive marketing claims. But does it actually have the authority?
The FTC put pharma giants on notice for deceptive marketing claims The FTC may have exaggerated its penalty authority for health firms, legal experts say. Be on the lookout, healthcare industry. The Federal Trade...
From silos to systems: Powering omnichannel marketing
From silos to systems: Powering omnichannel marketing Effective approaches shared during a Convene webinar for integration and creating a seamless experience. Despite the quest for omnichannel activation in pharma...
FDA approves Biogen and Ionis’ Tofersen for rare genetic form of ALS
FDA approves Tofersen for rare genetic form of ALS The FDA’s decision came just over a month after an advisory committee issued a mixed vote on Tofersen. The FDA approved Tofersen to treat SOD1-mutation-mediated ALS...
Five things for pharma marketers to know: Tuesday, April 25, 2023
Five things for pharma marketers to know: April 25 Bluebird Bio submitted an application for its sickle cell therapy lovo-cel to the Food and Drug Administration for approval. The FDA put another Foghorn Therapeutics...
Lots of Older Americans Would Like to Take Fewer Meds, Poll Finds
Lots of Older Americans Would Like to Take Fewer Meds A new study finds that Americans over 50 are interested in cutting back on prescription medications, dovetailing with a movement toward “deprescribing.” About 67%...
EMA validates marketing authorisation application for Jemperli with chemotherapy
EMA validates marketing authorisation application for Jemperli GSK has announced that the European Medicines Agency (EMA) has validated the company’s Type II Variation for a new indication for Jemperli (dostarlimab)...
Breaking down silos: Unifying HCP and DTC marketing for improved outcomes
Unifying HCP and DTC marketing for improved outcomes This TrendTalks session, sponsored by Swoop, highlighted new tactics for targeting DTC and HCP audiences. Increasingly, marketers are turning to ML/AI and real-world...
FDA Approves Cord Blood Stem Cell Product, Omisirge, for Blood Cancer Patients
FDA Approves Cord Blood Stem Cell Product, Omisirge, for Blood Cancer Patients The U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic cord blood-based cell...
Janssen Marks First Approval Worldwide for AKEEGA® with EC Authorisation for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer
Janssen Marks First Approval Worldwide for AKEEGA® Approval for AKEEGA® is based on results from the Phase 3 MAGNITUDE study, aprospectively designed precision medicine study that includes the largest cohort to date of...
The Wild West of cannabis marketing
The Wild West of cannabis marketing Patient and consumer interest couldn’t be higher. Here’s how marketers can meet demand. It’s a noisy frontier, full of confusing rules and messages. There’s no definitive playbook for...
